A Comprehensive Analysis of Hepatitis Transmission Routes and Clinical Differentiation of "Seroconversion" and "HBeAg Positive" Patients: Infectivity Assessment and Classification Treatment Decisions

III. Transmission Routes of Hepatitis Viruses Hepatitis A virus is mainly excreted through the intestines and transmitted orally through daily contact. The source of infection for Hepatitis A is acute patients and infected individuals, transmitted via the fecal-oral route. Hepatitis B virus can be excreted through various bodily fluids, such as blood, semen, vaginal secretions, saliva, breast milk, menstrual blood, tears, urine, and sweat. In fact, HBsAg has been detected in all secretions of patients. Therefore, there are three main routes of transmission for Hepatitis B: ① Mother-to-child transmission (vertical transmission): mainly caused by contact with maternal blood or amniotic fluid during childbirth and close contact after delivery. ② Iatrogenic transmission: transmitted through blood transfusions, plasma, blood products, or by using contaminated syringes, acupuncture needles, or blood collection equipment. ③ Close contact transmission (wound infection): transmitted through sexual contact or close contact through broken skin or mucous membranes. The source of infection for Hepatitis B is virus carriers in patients with acute or chronic hepatitis. Hepatitis C is mainly transmitted through blood transfusions, blood products, and wound infection. This disease accounts for over 70% of post-transfusion hepatitis (transfusion-transmitted viral hepatitis (TTV)). Hepatitis D is transmitted through the same routes as hepatitis B. High-risk groups include intravenous drug users, male homosexuals, prostitutes, and those who frequently use blood products or undergo kidney dialysis. Hepatitis E is primarily transmitted through contaminated water via the fecal-oral route. The hepatitis F virus has not yet been successfully isolated, and its pathogen is not yet identified or universally accepted. Currently, there is a lack of definitive and universally accepted pathogens for hepatitis F, and specific diagnostic methods are lacking; the exclusion method is still the primary approach, and its transmission routes are not entirely clear. The transmission routes of hepatitis G are basically the same as those of hepatitis B and hepatitis C; therefore, hepatitis G virus can co-infect with hepatitis C or hepatitis B viruses.

Section 2: "Triple Positive" and "Small Triple Positive" in Hepatitis B Patients While the terms "triple positive" and "small triple positive" are colloquial, they are not standardized medical terms. "Positive" here refers to the presence of hepatitis B virus antigens and antibodies in the serum of hepatitis B patients. These should be called markers of hepatitis B virus infection. Since there are three antigens and their corresponding three antibodies, the core antigen is usually not detected. Therefore, only two antigens and three antibodies are tested: the surface antigen (HBsAg) and the e antigen (HBeAg); the three antibodies are the surface antibody (anti-HBs), the core antibody (anti-HBc), and (anti-HBe). A positive result for HBsAg, HBeAg, and anti-HBc is called "triple positive," while a positive result for HBsAg, anti-HBc, and anti-HBe is called "small triple positive." I. Understanding "HBeAg Positive" and "HBeAg Positive" (I) What are "HBeAg Positive" and "HBeAg Positive"? "HBeAg Positive" and "HBeAg Positive" refer to two different results in a "Hepatitis B Antigen Two and a Half Rank" physical examination. The "Hepatitis B Antigen Two and a Half Rank" test ranks five indicators: Hepatitis B surface antigen (HBsAg), Hepatitis B surface antibody (HBsAb), Hepatitis B e antigen (HBeAg), Hepatitis B e antibody (HBeAb), and Hepatitis B core antibody (HBcAb). A positive result (or +) for items 1, 3, and 5 is usually called "HBeAg Positive," while a positive result (or +) for items 1, 4, and 5 is called "HBeAg Positive." Both HBeAg Positive and HBeAg Positive reflect the quantity and activity of the hepatitis B virus in the body; they only reflect the status of viral carriage and do not reflect the normality of liver function. Therefore, they cannot be used to determine the severity of the disease. (II) The Difference Between "HBeAg-positive" and "HBeAg-negative" Hepatitis B and Their Infectivity The terms "HBeAg-positive" and "HBeAg-negative" generally indicate that the individual is a hepatitis B virus carrier, not that they have hepatitis B. They are hepatitis B virus carriers, not patients. Hepatitis B is only diagnosed when "HBeAg-positive" or "HBeAg-negative" is accompanied by abnormal transaminase levels. Generally, "HBeAg-positive" indicates active viral replication, often accompanied by positive hepatitis B virus DNA (deoxyribonucleic acid), indicating strong infectivity and a higher likelihood of developing chronic hepatitis B. "HBeAg-negative," on the other hand, indicates that viral replication has essentially stopped, and infectivity is lower than "HBeAg-positive." If hepatitis B virus DNA is negative, infectivity is essentially eliminated. (III) The Prognosis of "HBeAg-positive" and the Transformation Between "HBeAg-positive" and "HBeAg-negative" When the immune function of a "HBeAg-positive" patient is activated, the immune system can recognize the hepatitis B virus antigens and virus-infected liver cells, resulting in a virus clearance response. This is a self-protective reaction of the body. The result is the clearance of a large number of viruses, but at the same time, infected liver cells are also destroyed, transaminase levels rise, and sometimes bilirubin levels rise (i.e., jaundice). However, this clearance is often incomplete, and viruses in a non-replicating state often cannot be killed and remain dormant. When the body's immunity declines, the virus begins to replicate again, infecting new liver cells and leading to a new round of immune attack. This repeated process of clearance and destruction is the process of chronic hepatitis development. As the virus is cleared from the blood, anti-HBe appears in the serum, and HBeAg disappears, thus changing from "HBeAg positive" to "HBeAg negative". Therefore, for most hepatitis B patients (except those infected with mutated viruses), the change from "HBeAg positive" to "HBeAg negative" signifies a decrease in viral replication and a reduction in the viral load, sometimes even to the point of being undetectable in the blood. Although "HBeAg positive" or "HBeAg negative" is not directly related to the severity of liver damage, the number of infected liver cells will decrease when the virus decreases, and the immune response and liver damage will also be reduced. Therefore, in treatment, we always hope to convert "HBeAg positive" to "HBeAg negative" to reduce viral replication to the lowest level, which is very beneficial to the patient. (IV) Transmission routes of "HBeAg positive" and "HBeAg negative" One of the main transmission routes of hepatitis B virus is through bodily fluids, and another major transmission route is mother-to-child transmission. Kissing, sexual intercourse, etc. can also transmit hepatitis B virus. (V) Does asymptomatic hepatitis B "HBeAg positive" need treatment? It can be said with certainty that no treatment is needed, but long-term observation is required. (1) Regularly check the evolution of "HBeAg positive" (usually every 3 months). (2) Regularly go to the hospital for health check-ups to check for symptoms and signs of liver disease, such as spider angiomas, palmar erythema, hepatosplenomegaly, etc., and check for abnormalities in liver function and protein metabolism. Regularly monitor transaminase levels. If elevated transaminase levels are found, seek medical treatment. If transaminase levels exceed three times the normal value, hospitalization is required. (3) Regularly undergo ultrasound examinations to assess liver and spleen condition. CT scans may be necessary in some cases. Liver biopsy may be required to determine disease progression. Patients must maintain a positive attitude towards the disease. "HBeAg positive" indicates the severity of the disease. Avoid abusing medication, drinking alcohol, and donating blood. However, moderate work and study are acceptable. II. Does "HBeAg negative" require treatment? Unlike hepatitis B patients, "HBeAg negative" individuals, despite carrying the hepatitis B virus, have no obvious symptoms. Liver function tests remain normal, and HBV DNA is negative. No special treatment is needed. With proper care, they can live a healthy life. Therefore, medication is not the focus; self-care is key.